Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT04122118
Brief Summary:
This trial studies how well pharmacist-led transitions of care works in the outpatient oncology infusion center for patients with solid tumor. Having a pharmacist in the outpatient oncology infusion center may help to identify and correct medical related problems and improve overall patient and staff satisfaction. Patients receiving education may benefit from gaining a better understanding of their antineoplastic therapy. Understanding the side effects associated with the therapy may also help patients better be prepared to manage any adverse effects they may experience.
Detailed Description:
PRIMARY OBJECTIVE:
I. To demonstrate the effectiveness of a clinical oncology pharmacist in the outpatient infusion center through education, and the identification and correction of medication related problem (MRP)s.
SECONDARY OBJECTIVE:
I. To evaluate overall patient and staff satisfaction with the added clinical oncology pharmacy education.
EXPLORATORY OBJECTIVE:
I. Estimate the cost avoidance utilizing the pharmacy services provided in the prospective trial.
OUTLINE:
PHASE I: Patients' medical records are reviewed.
PHASE II: Patients receive pharmacist-led education on antineoplastic therapies including what to expect during infusion, general drug facts, common adverse effects, side effect management, and when to contact provider.
After completion of study, patients are followed up periodically.
Study:
NCT04122118
Study Brief:
Protocol Section:
NCT04122118